Planar scintigraphy with 123I/99mTc-sestamibi, 99mTc-sestamibi SPECT/CT, 11C-methionine PET/CT, or selective venous sampling before reoperation of primary hyperparathyroidism?

@article{SchalinJntti2013PlanarSW,
  title={Planar scintigraphy with 123I/99mTc-sestamibi, 99mTc-sestamibi SPECT/CT, 11C-methionine PET/CT, or selective venous sampling before reoperation of primary hyperparathyroidism?},
  author={Camilla Schalin-J{\"a}ntti and Eeva M. Ryh{\"a}nen and Ilkka Heiskanen and Marko Sepp{\"a}nen and Johanna Arola and Jukka V Schildt and Mika V{\"a}is{\"a}nen and Lassi Nelimarkka and Irina Lisinen and Ville Aalto and Pirjo Nuutila and Matti V{\"a}lim{\"a}ki},
  journal={Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  year={2013},
  volume={54 5},
  pages={739-47}
}
UNLABELLED All patients with primary hyperparathyroidism should undergo localization studies before reoperation, but it is not known which method is most accurate. The purpose of this prospective study was to compare the performance of planar scintigraphy with (123)I/(99m)Tc-sestamibi, (99m)Tc-sestamibi SPECT (SPECT/CT), (11)C-methionine PET/CT, and selective venous sampling (SVS) in persistent primary hyperparathyroidism. METHODS Twenty-one patients referred for reoperation of persistent… CONTINUE READING
19 Citations
34 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 19 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 34 references

Similar Papers

Loading similar papers…